Pharmaceuticals company Abbott India announced Q2FY27 results Financial Highlights: Revenue from operations: For Q2FY27, revenue from operations was recorded at Rs 1,951.01 crore, displaying a growth of 7.57% QoQ from Rs 1,813.68 crore in Q1FY27 and a growth of 11.03% YoY from Rs 1,757.15 crore in Q2FY26. For H1FY27, revenue from operations reached Rs 3,764.69 crore, demonstrating a YoY growth of 7.7% against Rs 3,495.50 crore in H1FY26. Total income: For Q2FY27, total income stood at Rs 2,019.07 crore, increasing by 6.88% QoQ from Rs 1,889.05 crore in Q1FY27 and up 10.51% YoY from Rs 1,827.10 crore in Q2FY26. For H1FY27, total income amounted to Rs 3,908.12 crore, up 7.42% YoY compared to Rs 3,638.29 crore in H1FY26. Profit Before Tax (PBT): For Q2FY27, PBT reached Rs 610.47 crore, scaling up by 6.69% QoQ from Rs 572.21 crore in Q1FY27 and increasing by 11.82% YoY from Rs 545.93 crore in Q2FY26. For H1FY27, PBT expanded to Rs 1,182.68 crore, growing by 13.82% YoY against Rs 1,039.05 crore in H1FY26. Profit After Tax (PAT): For Q2FY27, PAT or net profit was reported at Rs 453.45 crore, higher by 5.82% QoQ than Rs 428.52 crore in Q1FY27 and higher by 9.19% YoY than Rs 415.27 crore in Q2FY26. For H1FY27, PAT stood at Rs 881.97 crore, showing a YoY growth of 12.91% compared to Rs 781.13 crore in H1FY26. Earnings per share (EPS): For Q2FY27, basic and diluted EPS was recorded at Rs 213.39, expanding by 5.82% QoQ from Rs 201.66 in Q1FY27 and growing by 9.2% YoY over Rs 195.42 in Q2FY26. For H1FY27, basic and diluted EPS stood at Rs 415.04, reflecting a YoY growth of 12.91% compared to Rs 367.59 in H1FY26. Result PDF